A C Altamura, R Whelpton, S H Curry
Index: Biopharm. Drug Dispos. 1(2) , 65-72, (1979)
Full Text: HTML
A model was developed for studying fluphenazine availability and disposition. Rats were given doses of radioactively labelled esters of fluphenazine by intramuscular injection. Radioactivity excreted in urine, faeces, and expired air was assessed for fluphenazine esters, fluphenazine, and CO2 content. Levels of fluphenazine and its esters were measured in plasma, brain, and muscle (injected and non-injected samples). The data mimicked those obtained in other studies involving the same material given to human subjects, and posed new questions concerning the factors controlling fluphenazine availability when given as 'long-acting' intramuscular injections.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Fluphenazine enanthate
CAS:2746-81-8 |
C29H38F3N3O2S |
|
Ten year outcomes of outpatients with schizophrenia on conve...
2013-09-01 [Int. Clin. Psychopharmacol. 28(5) , 261-6, (2013)] |
|
Treatment of schizophrenia with depot preparations of fluphe...
2010-06-01 [Schizophr. Res. 119(1-3) , 153-9, (2010)] |
|
Multiple congenital abnormalities in a newborn boy associate...
1982-03-01 [Acta Paediatr. Scand. 71(2) , 335-8, (1982)] |
|
[Effect of a single dose of some long-acting neuroleptics on...
1979-01-01 [C. R. Seances. Soc. Biol. Fil. 173(4) , 797-806, (1979)] |
|
Neuroleptic malignant syndrome.
1986-03-01 [South. Med. J. 79(3) , 331-6, (1986)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
